Source: European Journal of Preventive Cardiology. Unidade: HU
Subjects: DOENÇAS CARDIOVASCULARES, PREVENÇÃO PRIMÁRIA, VASOS CORONÁRIOS, CÁLCIO
ABNT
BITTENCOURT, Márcio Sommer et al. Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study. European Journal of Preventive Cardiology, v. 25, n. 17, p. 1887-1898, 2018Tradução . . Disponível em: https://doi.org/10.1177/2047487318788930. Acesso em: 15 out. 2024.APA
Bittencourt, M. S., Blankstein, R., Blaha, M. J., Sandfort, V., Agatston, A. S., Budoff, M. J., et al. (2018). Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study. European Journal of Preventive Cardiology, 25( 17), 1887-1898. doi:10.1177/2047487318788930NLM
Bittencourt MS, Blankstein R, Blaha MJ, Sandfort V, Agatston AS, Budoff MJ, Blumenthal RS, Krumholz HM, Nasir K. Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study [Internet]. European Journal of Preventive Cardiology. 2018 ; 25( 17): 1887-1898.[citado 2024 out. 15 ] Available from: https://doi.org/10.1177/2047487318788930Vancouver
Bittencourt MS, Blankstein R, Blaha MJ, Sandfort V, Agatston AS, Budoff MJ, Blumenthal RS, Krumholz HM, Nasir K. Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study [Internet]. European Journal of Preventive Cardiology. 2018 ; 25( 17): 1887-1898.[citado 2024 out. 15 ] Available from: https://doi.org/10.1177/2047487318788930